<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04771468</url>
  </required_header>
  <id_info>
    <org_study_id>STROKE_EMO</org_study_id>
    <nct_id>NCT04771468</nct_id>
  </id_info>
  <brief_title>&quot;Hemodynamic Changes During Endovascular Revascularization for Acute Stroke. An Observational Study&quot;.</brief_title>
  <official_title>&quot;Hemodynamic Changes During Endovascular Revascularization for Acute Stroke. An Observational Study&quot;.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Humanitas Clinical and Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ospedale Policlinico San Martino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Humanitas Clinical and Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurocardiology is an emerging specialty that addresses the interaction between the brain and&#xD;
      the heart, i.e. the effects of cardiac injury on the brain, and the effects of brain injury&#xD;
      on the heart. Accumulating clinical and experimental evidence suggests a causal relationship&#xD;
      between brain damage and heart dysfunction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output measurement</measure>
    <time_frame>Up to 6 hours after clot removal</time_frame>
    <description>Changes of cardiac output of the enrolled patients before and after clot removal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial elastance measurement</measure>
    <time_frame>Up to 6 hours after clot removal</time_frame>
    <description>Changes of arterial elastance of the enrolled patients before and after clot removal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial blood pressure measurement</measure>
    <time_frame>Up to 6 hours after clot removal</time_frame>
    <description>Changes of arterial blood pressure of the enrolled patients before and after clot removal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate variability measurement</measure>
    <time_frame>Up to 6 hours after clot removal</time_frame>
    <description>Changes of heart rate variability of the enrolled patients before and after clot removal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transthoracic echocardiography</measure>
    <time_frame>at the admission</time_frame>
    <description>Ejection Fraction measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transthoracic Echocardiography</measure>
    <time_frame>up to 3 weeks after clot removal</time_frame>
    <description>wave E assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transthoracic Echocardiography</measure>
    <time_frame>up to 3 weeks after clot removal</time_frame>
    <description>wave A assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transthoracic Echocardiography</measure>
    <time_frame>up to 3 weeks after clot removal</time_frame>
    <description>wave e' assessment</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Sovratentorial ischemic stroke</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MOSTCAREup Monitoring</intervention_name>
    <description>The patients will be equipped with mini-invasive hemodynamic monitoring (the MOSTACAREup system). The MOSTCAREup obtains the hemodynamic data from either the same arterial femoral line used by the neuro-radiologist to perform the treatment or from a dedicated radial artery, as decided by the attending anesthetist to monitor and optimize arterial pressure (the decision to use the arterial line is at discretion of the attending anesthetist for clinical reasons and does not delay the procedure, which starts using always the femoral access).</description>
    <arm_group_label>Sovratentorial ischemic stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ecocardiography</intervention_name>
    <description>Echocardiography will be performed 1) soon after the end of the treatment (whenever possible, avoiding delays, before od during the treatment in the angiography room); 2) at day 1 after the procedure; 3) at day 3 after the procedure.</description>
    <arm_group_label>Sovratentorial ischemic stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted for acute ischemic stroke&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          1. Adult patients aged â‰¥ 18 years.&#xD;
&#xD;
          2. Acute supratentorial or carotid stroke. Exclusion criteria&#xD;
&#xD;
        1. Invasive arterial signal unsuitable to obtain hemodynamic data. 2. Emergency&#xD;
        neurosurgery needed before intra-arterial treatment. 3. Once enrolled, the patient can be&#xD;
        excluded from the study because of one of the following intraoperative conditions:&#xD;
&#xD;
          1. Intraoperative technical limitations limiting or impeding the arterial re-opening&#xD;
&#xD;
          2. Persistent low quality of the arterial signal. After positioning the patient and&#xD;
             zeroing the arterial signal, the arterial waveform is checked for quality by means of&#xD;
             a square-wave test and optimized in the case of the occurrence of under or&#xD;
             over-damping.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>Milano</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Messina, MD</last_name>
      <phone>+390282241</phone>
      <email>antonio.messina@humanitas.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Messina, MD</last_name>
      <phone>+3902822414131</phone>
      <email>mess81rc@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>February 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The datasets used and/or analyzed during the current study will be available from the corresponding author on reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

